Biomedical Engineering Reference
In-Depth Information
182. Brand´n LJ, Mohamed AJ, Smith CI (1999) A peptide nucleic acid-nuclear localization
signal fusion that mediates nuclear transport of DNA. Nat Biotechnol 17:784-787
183. Carlisle RC, Bettinger T, Ogris M, Hale S, Mautner V, Seymour LW (2001) Adenovirus
hexon protein enhances nuclear delivery and increases transgene expression of polyethy-
lenimine/plasmid DNA vectors. Mol Ther 4:473-483
184. Nagasaki T, Myohoji T, Tachibana T, Futaki S, Tamagaki S (2003) Can nuclear localization
signals enhance nuclear localization of plasmid DNA? Bioconjug Chem 14:282-286
185. van der Aa MA, Koning GA, d'Oliveira C, Oosting RS, Wilschut KJ, Hennink WE,
Crommelin DJ (2005) An NLS peptide covalently linked to linear DNA does not enhance
transfection efficiency of cationic polymer based gene delivery systems. J Gene Med
7:208-217
186. Wagstaff KM, Jans DA (2007) Nucleocytoplasmic transport of DNA: enhancing non-viral
gene transfer. Biochem J 406:185-202
187. Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA (2000) Vector unpacking as a
potential barrier
for
receptor-mediated polyplex gene delivery. Biotechnol Bioeng
67:598-606
188. Remy JS, Kichler A, Mordvinov V, Schuber F, Behr JP (1995) Targeted gene transfer into
hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a
stage toward artificial viruses. Proc Natl Acad Sci USA 92:1744-1748
189. Budker V, Gurevich V, Hagstrom JE, Bortzov F, Wolff JA (1996) pH-sensitive, cationic
liposomes: a new synthetic virus-like vector. Nat Biotechnol 14:760-764
190. Behr JP (1997) The proton sponge: A trick to enter cells the viruses did not exploit. Chimia
51:34-36
191. Zuber G, Dauty E, Nothisen M, Belguise P, Behr JP (2001) Towards synthetic viruses. Adv
Drug Deliv Rev 52:245-253
192. Wagner E (2004) Strategies to improve DNA polyplexes for in vivo gene transfer: will
“artificial viruses” be the answer? Pharm Res 21:8-14
193. Martin B, Sainlos M, Aissaoui A, Oudrhiri N, Hauchecorne M, Vigneron JP, Lehn JM, Lehn
P (2005) The design of cationic lipids for gene delivery. Curr Pharm Des 11:375-394
194. Wagner E (2008) Converging paths of viral and non-viral vector engineering. Mol Ther 16:1-2
195. Sethuraman VA, Na K, Bae YH (2006) pH-responsive sulfonamide/PEI system for tumor
specific gene delivery: an in vitro study. Biomacromol 7:64-70
196. Knorr V, Allmendinger L, Walker GF, Paintner FF, Wagner E (2007) An acetal-based
PEGylation reagent for pH-sensitive shielding of DNA polyplexes. Bioconjug Chem
18:1218-1225
197. Sethuraman VA, Lee MC, Bae YH (2008) A biodegradable pH-sensitive micelle system for
targeting acidic solid tumors. Pharm Res 25:657-666
198. Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H,
Kikuchi H, Harashima H (2007) Development of a novel systemic gene delivery system for
cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 14:68-77
199. Meyer M, Wagner E (2006) pH-responsive shielding of non-viral gene vectors. Expert Opin
Drug Deliv 3:563-571
200. Knorr V, Ogris M, Wagner E (2008) An acid sensitive ketal-based polyethylene glycol-
oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity.
Pharm Res 25:2937-2945
201. Nie Y, Gunther M, Gu Z, Wagner E (2011) Pyridylhydrazone-based PEGylation for pH-
reversible lipopolyplex shielding. Biomaterials 32:858-869
202. Rozema DB, Ekena K, Lewis DL, Loomis AG, Wolff JA (2003) Endosomolysis by masking
of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug
Chem 14:51-57
203. Meyer M, Zintchenko A, Ogris M, Wagner E (2007) A dimethylmaleic acid-melittin-
polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and
enhanced gene transfer potential. J Gene Med 9:797-805
